Drew C. Deniger
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 5%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Cancer-related Molecular Pathways
Papers in
- Oncology 14
- CAR-T cell therapy research 14
- Cancer Immunotherapy and Biomarkers 4
- Immunology 10
- Immunotherapy and Immune Responses 5
- T-cell and B-cell Immunology 5
- Immune Cell Function and Interaction 4
- Co-authors
- Anna Pasetto (11 shared papers)Steven A. Rosenberg (11 shared papers)Paul F. Robbins (10 shared papers)Lee Jia (5 shared papers)Laurence J.N. Cooper (5 shared papers)Jared J. Gartner (6 shared papers)Maria R. Parkhurst (6 shared papers)Biman C. Paria (4 shared papers)
- Journals
- Clinical Cancer Research (3 papers)PLoS ONE (2 papers)Molecular Therapy (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesIsraelMalaysia
In The Last Decade
Drew C. Deniger
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 54
- Immunology 695
- Oncology 834
- Genetics 161
- Biotechnology 45
- Radiology, Nuclear Medicine and Imaging 92
Countries citing papers authored by Drew C. Deniger
This map shows the geographic impact of Drew C. Deniger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Drew C. Deniger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drew C. Deniger more than expected).
Fields of papers citing papers by Drew C. Deniger
This network shows the impact of papers produced by Drew C. Deniger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Drew C. Deniger. The network helps show where Drew C. Deniger may publish in the future.
Co-authors
The 25 scholars most cited alongside Drew C. Deniger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 199 | |
| 2 | 2019 | 156 | |
| 3 | 2019 | 115 | |
| 4 | 2018 | 112 | |
| 5 | 2019 | 109 | |
| 6 | 2014 | 106 | |
| 7 | 2007 | 87 | |
| 8 | 2014 | 84 | |
| 9 | 2016 | 55 | |
| 10 | 2016 | 53 | |
| 11 | 2016 | 45 | |
| 12 | 2015 | 44 | |
| 13 | 2020 | 22 | |
| 14 | 2006 | 16 | |
| 15 | 2023 | 6 | |
| 16 | 2015 | 3 | |
| 17 | 2016 | 2 | |
| 18 | 2015 | 1 |
About Drew C. Deniger
Drew C. Deniger is a scholar working on Oncology, Immunology, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Immunotherapy and Immune Responses (5 papers), T-cell and B-cell Immunology (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Cell Function and Interaction (4 papers), Cancer Genomics and Diagnostics (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Melanoma and MAPK Pathways (1 paper). The work is most often cited by research in Immunology (695 citations), Oncology (834 citations), Genetics (161 citations), Biotechnology (45 citations) and Radiology, Nuclear Medicine and Imaging (92 citations). Drew C. Deniger has collaborated with scholars based in United States, Israel and Malaysia. Frequent co-authors include Anna Pasetto, Steven A. Rosenberg, Paul F. Robbins, Lee Jia, Laurence J.N. Cooper, Jared J. Gartner, Maria R. Parkhurst, Biman C. Paria, Judy S. Moyes and Parisa Malekzadeh. Their work appears in journals such as Clinical Cancer Research, PLoS ONE, Molecular Therapy, Journal for ImmunoTherapy of Cancer and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.